DAVID RUIZ: Open Payments
NPI 1508803982 · VANCOUVER, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $279
Food & beverage: $279
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $124 |
| Antares Pharma, Inc. | 2 | $51 |
| Kowa Pharmaceuticals America, Inc. | 1 | $37 |
| Ascendis Pharma Endocrinology Inc | 1 | $30 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: CAPLYTA, XYOSTED, ZORYVE, Yorvipath, INSPIRE, SHINGRIX.
Industry payments across WA — which companies pay providers there.
